SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic placed unprecedented pressure on various healthcare systems, including departments that use immunotherapies such as chimeric antigen receptor (CAR) T-cell therapy and immunosuppression therapy in organ transplantation units. The true impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jia, Zhao, Jianping, Han, Meifang, Meng, Fankai, Zhou, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431770/
https://www.ncbi.nlm.nih.gov/pubmed/32727811
http://dx.doi.org/10.1136/jitc-2020-000862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431770/
https://www.ncbi.nlm.nih.gov/pubmed/32727811
http://dx.doi.org/10.1136/jitc-2020-000862

Ejemplares similares